Loading…
Loading…
ZBH · NYSE · Healthcare
“At 25 times earnings, this medical device manufacturer trades above my comfort zone unless extraordinary growth prospects justify such premium valuations over intrinsic worth.”
— In the voice of Graham
Track upcoming IPOs for the next three months. Filter by sector and expected valuation range.
Market Cap
$17.65B
P/E Ratio
25.04
Forward P/E
—
EPS
$3.56
PEG Ratio
-0.61
Book Value
$64.13
Dividend Yield
1.08%
Profit Margin
8.57%
ROE
5.55%
Use the interactive ipo calendar with pre-loaded data for Zimmer Biomet Holdings Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for ZBH: